|
HLCS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85947999999936E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.599100E-04 |
| Normal-vs-Stage2 |
2.783900E-02 |
| Normal-vs-Stage3 |
9.81480000050716E-07 |
| Normal-vs-Stage4 |
1.56371999999738E-05 |
| Stage1-vs-Stage2 |
3.765600E-01 |
| Stage1-vs-Stage3 |
1.067020E-01 |
| Stage1-vs-Stage4 |
1.047390E-01 |
| Stage2-vs-Stage3 |
4.695700E-02 |
| Stage2-vs-Stage4 |
5.071700E-02 |
| Stage3-vs-Stage4 |
8.193400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.0610000000264E-06 |
| Normal-vs-AfricanAmerican |
1.136210E-01 |
| Normal-vs-Asian |
1.83504999999862E-05 |
| Caucasian-vs-AfricanAmerican |
1.313170E-01 |
| Caucasian-vs-Asian |
4.431200E-01 |
| AfricanAmerican-vs-Asian |
3.849900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35139999996237E-06 |
| Normal-vs-Female |
8.36300000000012E-05 |
| Male-vs-Female |
2.430200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.359030E-04 |
| Normal-vs-Age(41-60Yrs) |
4.07940000002327E-06 |
| Normal-vs-Age(61-80Yrs) |
3.422300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.786200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.539400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.097400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.331600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.342600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.540600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.456200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.777130E-03 |
| Classical-VS-Follicular |
3.877000E-01 |
| Classical-VS-Other |
2.023200E-03 |
| Classical-VS-Normal |
8.06360000000783E-05 |
| Tall-VS-Follicular |
1.901010E-03 |
| Tall-VS-Other |
3.284600E-01 |
| Tall-VS-Normal |
1.23249999983699E-07 |
| Follicular-VS-Other |
6.440400E-04 |
| Follicular-VS-Normal |
1.884500E-02 |
| Other-VS-Normal |
1.64240000000149E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.592100E-04 |
| Normal-vs-N1 |
1.03789999994497E-06 |
| N0-vs-N1 |
2.410500E-02 |
|
|
